Intradiscal application of rhBMP-7 does not induce regeneration in a canine model of spontaneous intervertebral disc degeneration

IntroductionStrategies for biological repair and regeneration of the intervertebral disc (IVD) by cell and tissue engineering are promising, but few have made it into a clinical setting. Recombinant human bone morphogenetic protein 7 (rhBMP-7) has been shown to stimulate matrix production by IVD cells in vitro and in vivo in animal models of induced IVD degeneration. The aim of this study was to determine the most effective dose of an intradiscal injection of rhBMP-7 in a spontaneous canine IVD degeneration model for translation into clinical application for patients with low back pain.MethodsCanine nucleus pulposus cells (NPCs) were cultured with rhBMP-7 to assess the anabolic effect of rhBMP-7 in vitro, and samples were evaluated for glycosaminoglycan (GAG) and DNA content, histology, and matrix-related gene expression. Three different dosages of rhBMP-7 (2.5 μg, 25 μg, and 250 μg) were injected in vivo into early degenerated IVDs of canines, which were followed up for six months by magnetic resonance imaging (T2-weighted images, T1rho and T2 maps). Post-mortem, the effects of rhBMP-7 were determined by radiography, computed tomography, and macroscopy, and by histological, biochemical (GAG, DNA, and collagen), and biomolecular analyses of IVD tissue.ResultsIn vitro, rhBMP-7 stimulated matrix production of canine NPCs as GAG deposition was enhanced, DNA content was maintained, and gene expression levels of ACAN and COL2A1 were significantly upregulated. Despite the wide dose range of rhBMP-7 (2.5 to 250 μg) administered in vivo, no regenerative effects were observed at the IVD level. Instead, extensive extradiscal bone formation was noticed after intradiscal injection of 25 μg and 250 μg of rhBMP-7.ConclusionsAn intradiscal bolus injection of 2.5 μg, 25 μg, and 250 μg rhBMP-7 showed no regenerative effects in a spontaneous canine IVD degeneration model. In contrast, intradiscal injection of 250 μg rhBMP-7, and to a lesser extent 25 μg rhBMP-7, resulted in extensive extradiscal bone formation, indicating that a bolus injection of rhBMP-7 alone cannot be used for treatment of IVD degeneration in human or canine patients.

[1]  S. Vukicevic,et al.  Biological Repair of Thyroid Cartilage Defects by Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in Dog , 2000, Growth factors.

[2]  E. Thonar,et al.  Intradiscal Administration of Osteogenic Protein-1 Increases Intervertebral Disc Height and Proteoglycan Content in the Nucleus Pulposus in Normal Adolescent Rabbits , 2005, Spine.

[3]  E. Thonar,et al.  Cell Therapy Using Articular Chondrocytes Overexpressing BMP-7 or BMP-10 in a Rabbit Disc Organ Culture Model , 2008, Spine.

[4]  S. Chubinskaya,et al.  Osteogenic Protein-1 (Osteogenic Protein-1/Bone Morphogenetic Protein-7) Inhibits Degeneration and Pain-Related Behavior Induced by Chronically Compressed Nucleus Pulposus in the Rat , 2005, Spine.

[5]  Paramore Cg.  The safety of OP-1 for lumbar fusion with decompression-- a canine study. , 1999 .

[6]  P. Manley,et al.  Collagenolytic protease expression in cranial cruciate ligament and stifle synovial fluid in dogs with cranial cruciate ligament rupture. , 2005, Veterinary surgery : VS.

[7]  S. Chubinskaya,et al.  Anti‐catabolic effect of OP‐1 in chronically compressed intervertebral discs , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[8]  K. Masuda.  Biological repair of the degenerated intervertebral disc by the injection of growth factors , 2008, European Spine Journal.

[9]  E. Thonar,et al.  Intervertebral Disk Repair by Protein, Gene, or Cell Injection: A Framework for Rehabilitation‐Focused Biologics in the Spine , 2011, PM & R : the journal of injury, function, and rehabilitation.

[10]  E. Thonar,et al.  Recombinant Human Osteogenic Protein-1 Upregulates Proteoglycan Metabolism of Human Anulus Fibrosus and Nucleus Pulposus Cells , 2007, Spine.

[11]  J. Ralphs,et al.  Are animal models useful for studying human disc disorders/degeneration? , 2007, European Spine Journal.

[12]  L. Hellebrekers,et al.  Application of a modified form of the Glasgow pain scale in a veterinary teaching centre in the Netherlands , 2008, Veterinary Record.

[13]  M. Adams,et al.  What is Intervertebral Disc Degeneration, and What Causes It? , 2006, Spine.

[14]  P. Giannoudis,et al.  Application of recombinant BMP-7 on persistent upper and lower limb non-unions. , 2005, Injury.

[15]  E. Thonar,et al.  Osteogenic Protein-1 Injection Into a Degenerated Disc Induces the Restoration of Disc Height and Structural Changes in the Rabbit Anular Puncture Model , 2006, Spine.

[16]  E. Thonar,et al.  Recombinant osteogenic protein‐1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  H. Hazewinkel,et al.  Reliability of macroscopic grading of intervertebral disk degeneration in dogs by use of the Thompson system and comparison with low-field magnetic resonance imaging findings. , 2011, American journal of veterinary research.

[18]  Anne-Sofie Lagerstedt,et al.  The Dog as an Animal Model for Intervertebral Disc Degeneration? , 2012, Spine.

[19]  Lorenz Meinel,et al.  Localized delivery of growth factors for bone repair. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  M. Hadley,et al.  The safety of OP-1 for lumbar fusion with decompression-- a canine study. , 1999, Neurosurgery.

[21]  H. Oppermann,et al.  Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.

[22]  Paul D. Kim,et al.  Ectopic Bone Formation in the Pelvis After Combined Anterior and Posterior Fusion of the Spine With Osteogenic Protein-1 Use: A Case Report , 2010, Journal of spinal disorders & techniques.

[23]  E Viikari-Juntura,et al.  Low back pain in relation to lumbar disc degeneration. , 2000, Spine.

[24]  Vincenzo Denaro,et al.  Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation , 2012, Journal of tissue engineering and regenerative medicine.

[25]  Owen J. Marshall.  PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR , 2004, Bioinform..

[26]  A. de Bruin,et al.  The Paracrine Feedback Loop Between Vitamin D3 (1,25(OH)2D3) and PTHrP in Prehypertrophic Chondrocytes , 2014, Journal of cellular physiology.

[27]  K. Oka,et al.  Low-Dose Interleukin-1 Partially Counteracts Osteogenic Protein-1-Induced Proteoglycan Synthesis by Adult Bovine Intervertebral Disk Cells , 2005 .

[28]  李建平,et al.  1，25-（OH） , 2001 .

[29]  S. Chubinskaya,et al.  Regulation of osteogenic proteins by chondrocytes. , 2003, The international journal of biochemistry & cell biology.

[30]  H. Stegemann,et al.  Determination of hydroxyproline. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[31]  G. Voorhout,et al.  Evaluation of intervertebral disk degeneration in chondrodystrophic and nonchondrodystrophic dogs by use of Pfirrmann grading of images obtained with low-field magnetic resonance imaging. , 2011, American journal of veterinary research.

[32]  H. Hazewinkel,et al.  Intervertebral disc disease in dogs - part 1: a new histological grading scheme for classification of intervertebral disc degeneration in dogs. , 2013, Veterinary journal.

[33]  P. Giannoudis,et al.  Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects , 2005, Expert opinion on drug safety.

[34]  P. Aspenberg,et al.  OP-1 has more effect than mechanical signals in the control of tissue differentiation in healing rat tendons. , 1998, Acta orthopaedica Scandinavica.

[35]  Khoi D. Than,et al.  Bone Morphogenetic Proteins and Degenerative Disk Disease , 2012, Neurosurgery.

[36]  Christopher J Hunter,et al.  Cytomorphology of notochordal and chondrocytic cells from the nucleus pulposus: a species comparison , 2004, Journal of anatomy.

[37]  A. Reddi.  Bone and cartilage differentiation. , 1994, Current opinion in genetics & development.

[38]  P. Emans,et al.  Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7. , 2013, Osteoarthritis and cartilage.

[39]  이근호,et al.  ROI(Region Of Interest)기반의 차등적 이미지 압축에 관한 연구 , 2014 .

[40]  Juan Carlos Izpisúa Belmonte,et al.  Structural Basis of BMP Signaling Inhibition by Noggin, a Novel Twelve-Membered Cystine Knot Protein , 2003, The Journal of bone and joint surgery. American volume.

[41]  M. Fehlings,et al.  Notochordal cells protect nucleus pulposus cells from degradation and apoptosis: implications for the mechanisms of intervertebral disc degeneration , 2011, Arthritis research & therapy.

[42]  R W Farndale,et al.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. , 1982, Connective tissue research.

[43]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[44]  H. Brisby,et al.  Bone morphogenetic protein-7 protects human intervertebral disc cells in vitro from apoptosis. , 2008, The spine journal : official journal of the North American Spine Society.

[45]  A. Borthakur,et al.  Assessment of Human Disc Degeneration and Proteoglycan Content Using T1&rgr;-weighted Magnetic Resonance Imaging , 2006, Spine.

[46]  U. Ripamonti,et al.  Bone Induction by BMPs/OPs and Related Family Members in Primates: The Critical Role of Delivery Systems , 2001, The Journal of bone and joint surgery. American volume.

[47]  E. Thonar,et al.  Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. , 1996, Arthritis and rheumatism.

[48]  F. Luyten,et al.  Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of serum and osteogenic protein-1. , 1993, Biochemical and biophysical research communications.

[49]  V. Haughton,et al.  T2 Relaxation Times of Intervertebral Disc Tissue Correlated With Water Content and Proteoglycan Content , 2009, Spine.

[50]  W. Jianhong,et al.  Nucleus pulposus cells expressing hBMP7 can prevent the degeneration of allogenic IVD in a canine transplantation model , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[51]  H. Kristensen.  An improved method of decalcification. , 1948, Stain technology.

[52]  J. Freburger,et al.  The rising prevalence of chronic low back pain. , 2009, Archives of internal medicine.

[53]  T. Einhorn,et al.  Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. , 2008, The Journal of bone and joint surgery. British volume.